Microbiota — the Key to Treating Chronic Conditions
Reclaim your quality of life with microbiota transplantation. An evidence-based treatment for chronic gut conditions.
When Standard Treatment Falls Short
Problem
- Chronic GI issues: constipation, diarrhea, inflammation — treatment fails to provide lasting relief
- Recurring infections: antibiotics suppress symptoms but don't restore the microbiome
- Disrupted gut-brain axis: immunity, nervous system, and quality of life all suffer
Solution
- FMT restores a healthy microbiome by introducing bacteria from a screened donor
- Proven efficacy: up to 85.8% for C. difficile, 70.3% for chronic constipation (data from 15,000 patients)
- Choose your format: oil drops (480 billion bacteria per ml), capsules or microcapsules — taken by mouth, no surgery
What is Microbiota Transplantation?
What It Is
Fecal Microbiota Transplantation (FMT) is a method of restoring healthy microbiota by introducing a complete consortium of beneficial microorganisms from a rigorously screened healthy donor. It is not merely a mechanical transfer, but a bioengineered reconstruction of the intestinal ecosystem that restores the protective barrier and immune system.
Forms of Therapy
Microbiota is taken by mouth — this is not surgery. There are three forms: capsules (300 billion live bacteria per capsule), oil drops (480 billion per millilitre, given with a dropper) and microcapsules — dry granules with an acid-resistant coating. The doctor prescribes the form based on the patient's age and condition. Globally, Rebyota (FDA, 2022) and VOWST (FDA, 2023) have been approved — the first standardized microbiota-based products.
Who It's For
FMT is used for recurrent C. difficile infection (up to 85.8% efficacy), chronic constipation (70.3% improvement), inflammatory bowel disease, IBS, and autism spectrum disorder in children (70.6% improvement). Data based on analysis of 15,000 Han's United patients.
What Conditions Does FMT Help With?
C. difficile Infection
684 patients — clinical improvement in 85.8% at 3 months. The primary indication for FMT, recognized by the FDA and international societies.
GI Disorders
- Chronic constipation
- Ulcerative colitis and Crohn's disease
- Irritable bowel syndrome
- Chronic diarrhea
Autism & Neuropsychiatry
- Autism spectrum disorder (ASD)
- Depression and anxiety disorders
- Parkinson's disease
- Neurodegenerative diseases
- Intellectual disability (cognitive deficit)
- Speech and language delay
Metabolism
- Obesity
- Type 2 diabetes
- Metabolic syndrome
Your Path to Health: 5 Steps
Consultation
Connect via Telegram or WhatsApp, discuss symptoms and medical history with a doctor
Diagnostics
Sample collection kit, sent to the laboratory in Hangzhou, results in 7–10 days
Preparation
Stop antibiotics 3 days before, bowel preparation, PPI prescribed
Transplantation
Capsules (outpatient) or suspension (clinical setting), course of 3–6 days
Follow-Up
Monitoring via Telegram or WhatsApp, outcome assessment, repeat courses if needed
Consultation
Connect via Telegram or WhatsApp, discuss symptoms and medical history with a doctor
Diagnostics
Sample collection kit, sent to the laboratory in Hangzhou, results in 7–10 days
Preparation
Stop antibiotics 3 days before, bowel preparation, PPI prescribed
Transplantation
Capsules (outpatient) or suspension (clinical setting), course of 3–6 days
Follow-Up
Monitoring via Telegram or WhatsApp, outcome assessment, repeat courses if needed
A Method Backed by Science
Van Nood et al. (2013, NEJM): FMT cured 94% of patients with recurrent C. difficile infection versus 31% with vancomycin therapy. Tian Hongliang et al. (2025): analysis of 15,000 Han's United patients confirmed sustained FMT efficacy across a broad spectrum of conditions.— NEJM; Chinese Journal of Gastrointestinal Surgery
Who delivers the treatment
A clinic doctor leads the treatment; the manufacturer's research group runs the test and prepares the product.